Search Results - "Geoffrey W. McCaughan"

Refine Results
  1. 1

    Alcoholic Liver Disease in Asia, Europe, and North America by Liangpunsakul, Suthat, Haber, Paul, McCaughan, Geoff

    Published in Gastroenterology (New York, N.Y. 1943) (01-06-2016)
    “…Alcoholic liver diseases comprise a spectrum of clinical disorders and changes in liver tissue that can be detected by pathology analysis. These range from…”
    Get full text
    Journal Article
  2. 2

    COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? by Bassendine, Margaret F., Bridge, Simon H., McCaughan, Geoffrey W., Gorrell, Mark D.

    Published in Journal of diabetes (01-09-2020)
    “…The coronavirus disease 2019 (COVID‐19) pandemic is caused by a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), similar to…”
    Get full text
    Journal Article
  3. 3

    Current perspectives on the tumor microenvironment in hepatocellular carcinoma by Santhakumar, Cositha, Gane, Edward J., Liu, Ken, McCaughan, Geoffrey W.

    Published in Hepatology international (01-12-2020)
    “…Hepatocellular carcinoma (HCC) is a heterogeneous inflammation-driven malignancy, which, despite significant advances in management, continues to portend a…”
    Get full text
    Journal Article
  4. 4

    Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma by Vongsuvanh, Roslyn, van der Poorten, David, Iseli, Tristan, Strasser, Simone I, McCaughan, Geoffrey W, George, Jacob

    Published in PloS one (24-05-2016)
    “…Robust biomarkers for population-level hepatocellular carcinoma (HCC) surveillance are lacking. We compared serum midkine (MDK), dickkopf-1 (DKK1), osteopontin…”
    Get full text
    Journal Article
  5. 5

    Frailty in advanced liver disease by Laube, Robyn, Wang, Hogan, Park, Laura, Heyman, Joanne K., Vidot, Helen, Majumdar, Avik, Strasser, Simone I., McCaughan, Geoffrey W., Liu, Ken

    Published in Liver international (01-12-2018)
    “…Prognostication of patients with cirrhosis is complex, depending on more than just the severity of liver disease. Scores such as the model for end‐stage liver…”
    Get full text
    Journal Article
  6. 6

    Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives by Xu, Weiqi, Liu, Ken, Chen, Minjiang, Sun, Jin-Yu, McCaughan, Geoffrey W, Lu, Xiao-Jie, Ji, Jiansong

    “…The introduction of immunotherapies has been a major development in the treatment of many advanced cancers, including hepatocellular carcinoma (HCC). We are…”
    Get full text
    Book Review Journal Article
  7. 7

    A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs by English, Kieran, Kwan, Rain, Holz, Lauren E., McGuffog, Claire, Krol, Jelte M. M., Kempe, Daryan, Kaisho, Tsuneyasu, Heath, William R., Lisowski, Leszek, Biro, Maté, McCaughan, Geoffrey W., Bowen, David G., Bertolino, Patrick

    Published in Nature communications (10-02-2024)
    “…While CD4 + T cells are a prerequisite for CD8 + T cell-mediated protection against intracellular hepatotropic pathogens, the mechanisms facilitating the…”
    Get full text
    Journal Article
  8. 8

    Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? by Poustchi, Hossein, Farrell, Geoffrey C., Strasser, Simone I., Lee, Alice U., McCaughan, Geoffrey W., George, Jacob

    Published in Hepatology (Baltimore, Md.) (01-12-2011)
    “…Screening for hepatocellular carcinoma (HCC) is commonly practiced and recommended in published guidelines, but evidence for its efficacy has been…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Induction Phase of Spontaneous Liver Transplant Tolerance by McCaughan, Geoffrey W, Bowen, David G, Bertolino, Patrick J

    Published in Frontiers in immunology (11-09-2020)
    “…The liver has long been known to possess tolerogenic properties. Early experiments in liver transplantation demonstrated that in animal models, hepatic…”
    Get full text
    Journal Article
  11. 11

    Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling by Cochrane, Catherine R, Vaghjiani, Vijesh, Szczepny, Anette, Jayasekara, W Samantha N, Gonzalez-Rajal, Alvaro, Kikuchi, Kazu, McCaughan, Geoffrey W, Burgess, Andrew, Gough, Daniel J, Watkins, D Neil, Cain, Jason E

    Published in The Journal of clinical investigation (01-08-2020)
    “…Ligand-dependent activation of Hedgehog (Hh) signaling in cancer occurs without mutations in canonical pathway genes. Consequently, the genetic basis of Hh…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Hepatocyte entry leads to degradation of autoreactive CD8 T cells by Benseler, Volker, Warren, Alessandra, Vo, Michelle, Holz, Lauren E, Tay, Szun S, Le Couteur, David G, Breen, Eamon, Allison, Anthony C, van Rooijen, Nico, McGuffog, Claire, Schlitt, Hans J, Bowen, David G, McCaughan, Geoffrey W, Bertolino, Patrick

    “…Although most self-reactive T cells are eliminated in the thymus, mechanisms to inactivate or control T cells specific for extrathymic antigens are required…”
    Get full text
    Journal Article
  16. 16

    Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate by Liu, Ken, Chen, Jinbiao, Zhao, Yang, Boland, Jade, Ting, Ka Ka, Lockwood, Glen, McKenzie, Catriona, Kench, James, Vadas, Mathew A., Gamble, Jennifer R., McCaughan, Geoffrey W.

    Published in Frontiers in immunology (18-09-2023)
    “…Introduction Liver cancers exhibit abnormal (leaky) vasculature, hypoxia and an immunosuppressive microenvironment. Normalization of tumor vasculature is an…”
    Get full text
    Journal Article
  17. 17

    Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection by Adams, Leon A, Bulsara, Max, Rossi, Enrico, DeBoer, Bastiaan, Speers, David, George, Jacob, Kench, James, Farrell, Geoffrey, McCaughan, Geoffrey W, Jeffrey, Gary P

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2005)
    “…Staging hepatic fibrosis by liver biopsy guides prognosis and treatment of hepatitis C, but is invasive and expensive. We sought to create an algorithm of…”
    Get full text
    Journal Article
  18. 18

    Lamivudine Plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation by Gane, Edward J, Angus, Peter W, Strasser, Simone, Crawford, Darrell H.G, Ring, John, Jeffrey, Gary P, McCaughan, Geoffrey W

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-2007)
    “…Background & Aims: High-dose intravenous hepatitis B immunoglobulin (HBIG) may prevent recurrent hepatitis B virus (HBV) infection, but the cost has limited…”
    Get full text
    Journal Article
  19. 19

    dipeptidyl peptidase IV family in cancer and cell biology by Yu, Denise M.T, Yao, Tsun-Wen, Chowdhury, Sumaiya, Nadvi, Naveed A, Osborne, Brenna, Church, W. Bret, McCaughan, Geoffrey W, Gorrell, Mark D

    Published in The FEBS journal (01-03-2010)
    “…Of the 600+ known proteases identified to date in mammals, a significant percentage is involved or implicated in pathogenic and cancer processes. The…”
    Get full text
    Journal Article
  20. 20